PD-L1 expression in human cancers and its association with clinical outcomes
Work
Year: 2016
Type: review
Abstract: : PD-L1 is an immunoinhibitory molecule that suppresses the activation of T cells, leading to the progression of tumors. Overexpression of PD-L1 in cancers such as gastric cancer, hepatocellular carci... more
Source: OncoTargets and Therapy
Authors Jinming Yu, Xin Wang, Feifei Teng, Li Kong
Institutions Shandong Tumor Hospital, Shandong First Medical University, University of Jinan, Academy of Medical Sciences, Shandong University
Cites: 104
Cited by: 681
Related to: 10
FWCI: 8.823
Citation percentile (by year/subfield): 99.95
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,836